Antiprotozoal activity of different Xenorhabdus and Photorhabdus bacterial secondary metabolites and identification of bioactive compounds using the easyPACId approach.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 06 2022
Historique:
received: 27 04 2022
accepted: 26 05 2022
pubmed: 25 6 2022
medline: 29 6 2022
entrez: 24 6 2022
Statut: epublish

Résumé

Natural products have been proven to be important starting points for the development of new drugs. Bacteria in the genera Photorhabdus and Xenorhabdus produce antimicrobial compounds as secondary metabolites to compete with other organisms. Our study is the first comprehensive study screening the anti-protozoal activity of supernatants containing secondary metabolites produced by 5 Photorhabdus and 22 Xenorhabdus species against human parasitic protozoa, Acanthamoeba castellanii, Entamoeba histolytica, Trichomonas vaginalis, Leishmania tropica and Trypanosoma cruzi, and the identification of novel bioactive antiprotozoal compounds using the easyPACId approach (easy Promoter Activated Compound Identification) method. Though not in all species, both bacterial genera produce antiprotozoal compounds effective on human pathogenic protozoa. The promoter exchange mutants revealed that antiprotozoal bioactive compounds produced by Xenorhabdus bacteria were fabclavines, xenocoumacins, xenorhabdins and PAX peptides. Among the bacteria assessed, only P. namnaoensis appears to have acquired amoebicidal property which is effective on E. histolytica trophozoites. These discovered antiprotozoal compounds might serve as starting points for the development of alternative and novel pharmaceutical agents against human parasitic protozoa in the future.

Identifiants

pubmed: 35750682
doi: 10.1038/s41598-022-13722-z
pii: 10.1038/s41598-022-13722-z
pmc: PMC9232601
doi:

Substances chimiques

Antiprotozoal Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10779

Informations de copyright

© 2022. The Author(s).

Références

Antimicrob Agents Chemother. 2001 Feb;45(2):532-9
pubmed: 11158751
Nat Chem Biol. 2011 Sep 18;7(12):888-90
pubmed: 21926994
J Appl Microbiol. 2008 Mar;104(3):745-58
pubmed: 17976177
J Nat Prod. 2012 Mar 23;75(3):311-35
pubmed: 22316239
Angew Chem Int Ed Engl. 2019 Dec 19;58(52):18957-18963
pubmed: 31693786
Front Microbiol. 2018 Dec 19;9:3177
pubmed: 30619229
Sci Rep. 2020 Nov 26;10(1):20649
pubmed: 33244079
Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11909-13
pubmed: 7991556
Res Microbiol. 2004 May;155(4):224-30
pubmed: 15142618
J Pharm Pharmacol. 2018 Mar;70(3):426-433
pubmed: 29411390
Nat Chem. 2022 Jun;14(6):701-712
pubmed: 35469007
J Infect Dis. 1986 May;153(5):948-55
pubmed: 3486237
Antimicrob Agents Chemother. 1982 Oct;22(4):541-7
pubmed: 6758684
Chembiochem. 2014 Mar 3;15(4):512-6
pubmed: 24532262
Appl Environ Microbiol. 2015 Feb;81(3):1139-46
pubmed: 25452285
Chembiochem. 2013 Oct 11;14(15):1991-7
pubmed: 24038745
PLoS One. 2013;8(1):e54143
pubmed: 23349809
Clin Microbiol Rev. 2002 Jul;15(3):329-41
pubmed: 12097242
Nat Prod Rep. 2018 Apr 25;35(4):309-335
pubmed: 29359226
Appl Environ Microbiol. 2006 Sep;72(9):5895-907
pubmed: 16957209
Front Microbiol. 2019 Nov 22;10:2672
pubmed: 31824457
J Nat Prod. 2014 Apr 25;77(4):779-83
pubmed: 24673206
BMC Genomics. 2017 Dec 01;18(1):927
pubmed: 29191166
J Nat Prod. 1995 Jul;58(7):1081-6
pubmed: 7561900
Beilstein J Org Chem. 2020 May 7;16:956-965
pubmed: 32461774
J Clin Microbiol. 2003 Jan;41(1):506-8
pubmed: 12517908
Sci Rep. 2014 Mar 06;4:4300
pubmed: 24599183
Parasitol Res. 2012 Jun;110(6):2563-7
pubmed: 22231263
Nat Microbiol. 2017 Dec;2(12):1676-1685
pubmed: 28993611
Antimicrob Agents Chemother. 2014;58(3):1523-8
pubmed: 24366747
Bull World Health Organ. 2010 Mar;88(3):199-205
pubmed: 20428387
Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):115-22
pubmed: 18221167
Mol Microbiol. 2009 Sep;73(5):938-49
pubmed: 19682255
J Ind Microbiol Biotechnol. 2021 Jun 4;48(3-4):
pubmed: 33693901
Exp Parasitol. 2019 Sep;204:107724
pubmed: 31279930
Appl Microbiol Biotechnol. 2021 Jul;105(13):5517-5528
pubmed: 34250572
Syst Appl Microbiol. 2004 Feb;27(1):36-42
pubmed: 15053319
Curr Opin Chem Biol. 2009 Apr;13(2):224-30
pubmed: 19345136
Parasitol Res. 2009 Mar;104(4):935-7
pubmed: 19089450
Adv Biochem Eng Biotechnol. 2013;135:123-55
pubmed: 23657492
Clin Microbiol Rev. 1999 Oct;12(4):564-82
pubmed: 10515903
Ann N Y Acad Sci. 2015 Sep;1354:82-97
pubmed: 26509922
J Appl Microbiol. 2011 Sep;111(3):652-62
pubmed: 21699632
J Antibiot (Tokyo). 2013 Oct;66(10):617-20
pubmed: 23756685
J Gen Microbiol. 1947 Jun;1(2):158-67
pubmed: 20251276
Photodiagnosis Photodyn Ther. 2019 Dec;28:166-171
pubmed: 31499180
PLoS One. 2011;6(11):e27909
pubmed: 22125637
J Gen Microbiol. 1982 Dec;128(12):3061-5
pubmed: 7183749
Chembiochem. 2015 May 4;16(7):1115-9
pubmed: 25826784
Curr Med Chem. 2006;13(27):3335-50
pubmed: 17168847
Microb Ecol. 2012 Oct;64(3):617-27
pubmed: 22526402
Trans R Soc Trop Med Hyg. 1978;72(4):431-2
pubmed: 212851
Int J Antimicrob Agents. 2012 Jul;40(1):61-71
pubmed: 22591838
Sci Rep. 2021 May 27;11(1):11253
pubmed: 34045620
Phytomedicine. 2015 Oct 15;22(11):969-74
pubmed: 26407938
J Antibiot (Tokyo). 2009 Jun;62(6):295-302
pubmed: 19373275
Parasitol Int. 2014 Oct;63(5):698-700
pubmed: 24929036
Biotech Histochem. 2010 Dec;85(6):341-54
pubmed: 21080764
Antimicrob Agents Chemother. 2013 Aug;57(8):3561-7
pubmed: 23669391
Parasitol Res. 2014 Aug;113(8):2933-40
pubmed: 24880238
Int J Syst Evol Microbiol. 2018 Aug;68(8):2664-2681
pubmed: 29877789
Parasitol Res. 2011 Dec;109(6):1609-17
pubmed: 21541750
World J Microbiol Biotechnol. 2017 May;33(5):84
pubmed: 28378222
Front Microbiol. 2017 Jun 28;8:1142
pubmed: 28702004
Mol Microbiol. 2007 Apr;64(2):260-8
pubmed: 17493120
J Nat Prod. 1991 May-Jun;54(3):785-95
pubmed: 1955881
Heliyon. 2020 Sep 14;6(9):e04805
pubmed: 32984575
Infect Dis Poverty. 2014 Jul 31;3:21
pubmed: 25110585
Int J Parasitol. 2000 Jun;30(7):829-35
pubmed: 10899527

Auteurs

Sebnem Hazal Gulsen (SH)

Department of Biology, Faculty of Arts and Science, Aydin Adnan Menderes University, Aydin, Türkiye.

Evren Tileklioglu (E)

Department of Parasitology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye.

Edna Bode (E)

Max-Planck-Institute for Terrestrial Microbiology Department, Natural Products in Organismic Interactions, Karl-von-Frisch-Str. 10, 35043, Marburg, Germany.

Harun Cimen (H)

Department of Biology, Faculty of Arts and Science, Aydin Adnan Menderes University, Aydin, Türkiye.

Hatice Ertabaklar (H)

Department of Parasitology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye.

Derya Ulug (D)

Department of Biology, Faculty of Arts and Science, Aydin Adnan Menderes University, Aydin, Türkiye.

Sema Ertug (S)

Department of Parasitology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye.

Sebastian L Wenski (SL)

Max-Planck-Institute for Terrestrial Microbiology Department, Natural Products in Organismic Interactions, Karl-von-Frisch-Str. 10, 35043, Marburg, Germany.

Mustapha Touray (M)

Department of Biology, Faculty of Arts and Science, Aydin Adnan Menderes University, Aydin, Türkiye.

Canan Hazir (C)

Aydin Health Services Vocational School, Aydin Adnan Menderes University, 09100, Aydin, Türkiye.

Duygu Kaya Bilecenoglu (DK)

Faculty of Health Science, Aydin Adnan Menderes University, 09100, Aydin, Türkiye.

Ibrahim Yildiz (I)

Department of Parasitology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye.

Helge B Bode (HB)

Max-Planck-Institute for Terrestrial Microbiology Department, Natural Products in Organismic Interactions, Karl-von-Frisch-Str. 10, 35043, Marburg, Germany. helge.bode@mpi-marburg.mpg.de.
Molekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe Universität Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany. helge.bode@mpi-marburg.mpg.de.
Senckenberg Gesellschaft für Naturforschung, 60325, Frankfurt, Germany. helge.bode@mpi-marburg.mpg.de.

Selcuk Hazir (S)

Department of Biology, Faculty of Arts and Science, Aydin Adnan Menderes University, Aydin, Türkiye. selcuk.hazir@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH